Tag Archives: VRX

Top Canadian Stocks To Invest In Right Now

Editor’s note: Seeking Alpha is proud to welcome Jeff Khoshaba as a new contributor. It’s easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more 禄

Much of the focus of cannabis investors has been centered on Canada and California. This makes sense given that they are the two largest recreational (or soon to be) cannabis markets in the world. However, one publicly traded company with US-centric cannabis operations has taken a different approach. iAnthus Capital is listed in Canada on the CSE (OTCQB:ITHUF), but is headquartered in New York and incorporated in Delaware. Unlike other Canadian-listed cannabis companies, most of which are aiming to get in on the highly competitive green-rush in California and Canada, iAnthus has set its sights on becoming the dominant player on the U.S. East Coast.

iAnthus’s strategy centers around building a portfolio of vertically integrated cannabis assets in markets that have significant barriers to entry, i.e., a limited number of licenses. While the Canadian and California markets are both larger than any other single state market in the US, they have low barriers to entry and, as a result, have a significantly higher ratio of growers and operators to consumers. This, combined with the fact that California and Canada are both renowned for their cannabis growing expertise, has led to fears of an ultra-competitive environment where most profits will be competed away as companies fight for market share. The east coast markets where iAnthus’s core assets are located, on the other hand, have a limited number of competitors, and when combined, add up to a population size significantly larger than either California or Canada.

Top Canadian Stocks To Invest In Right Now: PPL Corporation(PPL)

Advisors’ Opinion:

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $32.48 after closing Monday at $33.97. The 52-week high is $40.20. Volume was about 5.9 million, nearly a third higher than the daily average of around 3.9 million shares. The electric utility company had no specific news.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) dropped about 1.7% Tuesday to post a new 52-week low of $30.44 after closing at $30.95 on Friday. Volume was around 4.1 million about 10% below the daily average of around 4.6 million. The company had no specific news.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $30.74 after closing Tuesday at $30.76. The 52-week high is $40.20. Volume was about 3.2 million, about 25% below the daily average of around 4.5 million shares. The electric utility company had no specific news.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $31.11 after closing Wednesday at $31.59. The 52-week high is $40.20. Volume was about 9.6 million, more than double the daily average of around 4.2 million shares. The electric utility company had no specific news.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $31.53 after closing Tuesday at $32.42. The 52-week high is $40.20. Volume was about 15.5 million, more than three times the daily average of around 4 million shares. The electric utility company took a downgrade on Tuesday and the fallout continues to drop.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $30.81 after closing Friday at $31.13. The 52-week high is $40.20. Volume was about 3.5 million, about 25% below the daily average of around 4.5 million shares. The electric utility company had no specific news.

Top Canadian Stocks To Invest In Right Now: Silver Wheaton Corp(SLW)

Advisors’ Opinion:

  • [By Rich Duprey]

    Silver Wheaton (NYSE:SLW), of course, is a streamer like Sandstorm and Franco, but it is the largest in the precious-metals industry, and arguably the best-known, because its business model came to define what streaming is. Although it is known primarily for its silver contracts, Silver Wheaton also has sizable gold production that makes it worth your attention.

Top Canadian Stocks To Invest In Right Now: 3M Company(MMM)

Advisors’ Opinion:

  • [By ]

    The Caterpillar news was followed by 3M (MMM) , which lowered full-year guidance, sending its shares down 6.8%. Lockheed Martin (LMT) then delivered blowout earnings, but mentioned that its cash flow might be challenged. Shares fell 6.1%.

  • [By Ben Levisohn]

    Second, how will the Dow get to that big magic number? Well, the six biggest stock weightings in the DJIA are: Goldman Sachs (GS), 3M (MMM), International Business Machines (IBM), UnitedHealth Group (UNH), and Boeing (BA). What you will notice looking at a day like yesterday is that tech led the way sector wise. If the Dow is going to outperform, we need mega caps to outperform. We need those six stocks to outperform. So we need a day where financials and industrials outperform to get there. Given the trends in sector leadership, that is bound to happen…We are one Trump tweet talking about how yuuuuuuge Goldman Sachs is away from 20k.

  • [By Chris Lange]

    3M Co. (NYSE: MMM) reported its first-quarter earnings results before the markets opened on Tuesday. The company posted $2.50 in earnings per share (EPS) on $8.28 billion in revenue, which compares with consensus estimates of $2.52 in EPS on revenue of $8.26 billion. In the same period of last year, 3M said it had EPS of $2.16 and $7.68 billion in revenue.

  • [By Keith Fitz-Gerald]

    First, the Dow dropped below 19,800 points with two stocks – The Goldman Sachs Group Inc. (NYSE:GS) and 3M Company (NYSE:MMM) – experiencing a $3.26 billion selloff alone. Big banking stocks including Wells Fargo & Company (NYSE:WFC) and JPMorgan Chase and Co. (NYSE:JPM) sold off far more severely than the S&P 500 itself. Tech stocks were more or less unscathed, with the exception of Alphabet Inc. (NasdaqGS:GOOG), which received a 2.55% buzzcut of $26 per share.

Top Canadian Stocks To Invest In Right Now: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By Sean Williams]

    Shares of Valeant Pharmaceuticals (NYSE:VRX), an embattled drug developer whose primary method of growth over the past couple of years has been via acquisitions and price hikes on its therapies, surged as much as 15% on Thursday for their third consecutive day of strong gains. The stock was up a more modest 9% as of the closing bell.

  • [By Ben Levisohn]

    Valeant Pharmaceuticals International (VRX) has jumped 4.3% to $11.68 after activist investor ValueAct bought three million shares of the beaten-down specialty pharmaceutical company.

  • [By Stark Merrifield]

    Bill Ackman: Fifty-year-old Ackmans career began in 1992 when he and fellow Harvard graduate David P. Berkowtiz founded the investment firm Gotham Partners. The firms high-profile bid for Rockefeller Center in New York caused investors to flock to the firm, growing it to $500 million in assets. Then in 2004, with $54 million in personal funding, Ackman started Pershing Square Capital Management. Through Pershing, Ackman bought significant shares in companies like Wendys Co. (Nasdaq: WEN), Target Corp. (NYSE: TGT), Chipotle Mexican Grill Inc. (NYSE: CMG), and Valeant Pharmaceuticals International Inc. (NYSE: VRX). Today, Ackman is worth $1.4 billion and is No. 256 on the Forbes 400.

  • [By Vikram Nagarkar]

    Shares of Nvidia (NSDQ:NVDA) tumbled nearly 7% yesterday, after a bearish call by famed short seller Citron Research, which said that “NVDA Belongs At $90”. Citron, headed by Andrew Left, has built a reputation for “unleashing eye-catching claims against companies that send their shares tanking”, asAntoine Gara ofForbes puts it. Citron’s claims have in the past unleashed the markets’ wrath on stocks like Valeant (NYSE:VRX) and Facebook (NSDQ:FB), among others, and the impact on Nvidia seems to have been no different.

  • [By Ashley Moore]

    The current rally of Valeant Pharmaceuticals International Inc. (NYSE: VRX) is being driven by two things. While investors are viewing these two catalysts as bullish, they are really just temporary solutions.

  • [By Virendra Singh Chauhan]

    Nvidia corporation stock shook off the bad performance from the last week, with a nearly 3% gain in the first trading session of this week. If you are wondering whether or not NVIDIA stock has turned the corner, a recent tweet from NVIDIA bear Andrew Left offers some answers. In late December, Citron’s Andrew Left issued a bearish NVDA call, calling a $90 bottom on the stock. Well, the famed short seller of Valeant (NYSE:VRX) fame, recently disclosed that he had covered its short position on NVIDIA. Given that Citron had originally called for a $90 price target, it appears likely that Citron thinks NVDA stock has bottomed out $10 above its original target.

Hot Canadian Stocks To Invest In Right Now

Barclays analyst Thomas Driscoll and team see more dividend cuts and equity raises coming for oil & gas stocks like Apache (APA), Devon Energy (DVN),Encana (ECA), Anadarko Petroleum (APC), and Marathon Oil (MRO). They explain why:

Bloomberg News

Leverage concerns will lead E&P companies to take strong steps to strengthen balance sheets. As oil price weakness has lingered, management teams have become more willing to take stronger steps to address leverage. We view 4x debt to pre-interest cash flow as a warning sign that companies may be overlevered. At a $30-40/bbl WTI oil price, debt to estimated pre-interest cash is over 4x for 16-19 of the companies we cover. At $50 oil, roughly half of our coverage universe remains overlevered using our 4x coverage test…

We have seen several dividend cuts in the recent past, including Anadarko Petroleum cutting its dividend by 81%…and we expect more companies to follow suit. Chesapeake Energy (CHK), ConocoPhillips (COP), Encana,Marathon Oil and Noble Energy (NBL) are among energy companies that have also cut dividends in the past 12 months, but dividend requirements even after several cuts will consume ~26% of 2016 estimated cash flow at current dividend rates (15% excluding Occidental Petroleum (OXY)) for the large cap E&Ps we cover. We believe most of the companies with a dividend yield of more than 1.5% should consider cutting the dividend and find the following companies more likely than not to reduce dividends:Apache (2.5% yield),Devon Energy (4%),Encana (1.5%) andMarathon Oil (2.5%). We believe Canadian Natural Resource (CNQ) (3.0%) is likely to maintain its dividend while Occidental (4.5%) has the financial strength to maintain or even increase the dividend…

Hot Canadian Stocks To Invest In Right Now: Transcananda Pipelines Ltd.(TRP)

Advisors’ Opinion:

  • [By Paul Ausick]

    That includes pipeline companies like Kinder Morgan Inc. (NYSE: KMI), which already operates a pipeline transporting natural gas from Texas into Mexico, and master limited partnerships (MLPs) Energy Transfer Partners L.P. (NYSE: ETP) and TransCanada Corp. (NYSE: TRP), the company that has (so far) failed to get U.S. approval for its Keystone Pipeline expansion from Canada’s oil sands across the U.S. border.

  • [By Dustin Parrett]

    TransCanada Corp. (NYSE: TRP) just achieved a perfect Money Morning stock VQScore, making it a profit powder keg waiting to ignite…

    TransCanada is a Canadian oil and gas pipeline company, most famous for its development of the Keystone XL pipeline connecting Canadian oil fields to major hubs in the United States.

  • [By Matthew DiLallo]

    After a series of setbacks in its attempts to build new oil pipelines, Canadian pipeline giant TransCanada (NYSE:TRP) completed a transformation transaction to acquire U.S. natural gas pipeline company Columbia Pipeline Group for $13 billion, which includes the assumption of debt. The key to that deal was that it increased the combined company’s near-term project pipeline to 23 billion Canadian dollars, which supports TransCanada’s ability to increase its dividend by 8% to 10% annually through 2020. After completing that deal, TransCanada made a bid to acquire all of the outstanding units that it did not own of affiliated MLP Columbia Pipeline Partners (NYSE:CPPL) in a transaction valued at $915 million. These acquisitions solidified TransCanada’s natural gas pipeline growth ambitions, enabling it to diversify away from oil pipelines.

  • [By Paul Ausick]

    In addition to the Trans Mountain system, two other pipeline projects currently are proposed to move crude oil from Alberta either to the Great Lakes or the Gulf Coast. Enbridge Inc. (NYSE: ENB) is proposing to replace its 50-year old Line 3 system to transport 760,000 barrels a day to Superior, Wisconsin. TransCanada Corp. (NYSE: TRP) has received approval from the Trump administration and would transport 830,000 barrels a day to Nebraska where existing pipelines will take over, sending the crude to U.S. refineries and Gulf Coast terminals.

Hot Canadian Stocks To Invest In Right Now: Thor Industries Inc.(THO)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Finally, shares of Winnebago Industries dropped 6%. The maker of recreational vehicles has been under pressure ever since rival Thor Industries (NYSE:THO) reported its most recent quarterly results earlier this week, and Thor’s story led shareholders to sell off that stock. Yet although Winnebago is in the same business as Thor, some investors think that it could succeed where Thor failed, especially because the Winnebago brand name is much more valuable and has greater customer recognition that many of its competitors’ offerings. Winnebago will have its own chance to report its financial results later this month, and although many investors seem to be betting against the RV maker, others believe that Winnebago could easily make its competitive advantage against Thor and other manufacturers clear with a solid performance this quarter.

  • [By Lisa Levin]

    Thor Industries, Inc. (NYSE: THO) shares were also up, gaining 13 percent to $154.01 after the company reported stronger-than-expected results for its first quarter on Monday.

  • [By Elizabeth Balboa]

    Supply could come from any number of industry players, including Winnebago Industries, Inc. (NYSE: WGO), Thor Industries, Inc. (NYSE: THO), Polaris Industries Inc. (NYSE: PII) and Camping World Holdings Inc (NYSE: CWH). However, whether it comes from existing inventory and whether suppliers can meet the demand are yet to be seen.

  • [By WWW.MONEYSHOW.COM]

    One of the world’s largest makers of recreational vehicles, Thor Industries (THO) is in the right place at the right time.

    Industrywide wholesale RV shipments for the U.S. and Canada surged 15% to nearly 431,00 units in 2016 — the highest annual total in more than 40 years, according to The Recreation Vehicle Industry Association.

Hot Canadian Stocks To Invest In Right Now: Plains All American Pipeline L.P.(PAA)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    One of the largest projects is the Saddlehorn Pipeline, which Magellan is building with Plains All American Pipeline (NYSE:PAA) and Anadarko Petroleum (NYSE:APC). Both Plains All American Pipeline and Magellan own 40% of the project, which puts their total investment at $230 million apiece. They expect the project to be fully operational early next year, which is noteworthy given its robust first-year economics. Magellan estimates that it will earn eight times EBITDA on the capital deployed, or roughly $28.8 million in annual EBITDA apiece for Magellan and Plains All American Pipeline on their investment.

  • [By Dustin Parrett]

    We think Plains All American Pipeline L.P. (NYSE: PAA) is one of the best oil stocks to buy this year. In fact, we see a scenario where PAA stock could jump 20% in 2017.

  • [By Dustin Parrett]

    Plains All American Pipeline (NYSE: PAA) controls 4 million barrels of crude oil and natural gas a day.

    And with higher oil prices and fewer restrictions leading to more drilling, PAA’s pipelines will be in demand in 2017.

Hot Canadian Stocks To Invest In Right Now: Safeway Inc.(SWY)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap SUPERVALU now underperforming large cap Kroger Co (NYSE: KR) while shares of large cap Whole Foods Market, Inc (NASDAQ: WFM) and mid cap Safeway Inc (NYSE: SWY) appear to be back to where they started at:

  • [By Peter Graham]

    A long term performance chart shows shares of SUPERVALU underperforming the underperformance ofmid caps Whole Foods Market, Inc (NASDAQ: WFM) and Safeway Inc (NYSE: SWY). while large capKroger Co (NYSE: KR)had outperformed up until the last two years when performance has been more mixed:

Hot Canadian Stocks To Invest In Right Now: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By Virendra Singh Chauhan]

    Nvidia corporation stock shook off the bad performance from the last week, with a nearly 3% gain in the first trading session of this week. If you are wondering whether or not NVIDIA stock has turned the corner, a recent tweet from NVIDIA bear Andrew Left offers some answers. In late December, Citron’s Andrew Left issued a bearish NVDA call, calling a $90 bottom on the stock. Well, the famed short seller of Valeant (NYSE:VRX) fame, recently disclosed that he had covered its short position on NVIDIA. Given that Citron had originally called for a $90 price target, it appears likely that Citron thinks NVDA stock has bottomed out $10 above its original target.

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) made waves early on Tuesday after the company offered a plethora of announcements. First the company gave an update on its late-stage psoriasis trial. Along with this success, Valeant reported the sale of a couple of its business segments, bringing in a sizable amount of cash.

  • [By Ben Levisohn]

    If it feels like it’s been all Valeant Pharmaceuticals International (VRX) today, I get it, and I promise this will be my last post on the company today. But really, how often do we get to see a fund manager acknowledge a spectacular mistake in such publicfashion?

    Photo: Andrew Harrer/Bloomberg

    As if it weren’t obvious yet, Ackman’s exit is bad news for the stock.Yes, some analysts have tried to focus on other issues that could be positive, but, really, as long as Ackman was around, you knew someone big had Valeant’s back. And now he’s gone. We at Barron’s were never too enthusiastic about Valeant–Vito Racanelliwrote bearishly on the company 2014–or Ackman’s involvement. But it he was your reason to be in Valeant, well consider what Wells Fargo analyst David Maris has to say:

    …we believe investors will take Pershing Squares exit as a reflection that 1) the outlook is negative; 2) the potential for meaningful near-term asset sales is unlikely; 3) the legal proceedings/investigations may have greater risk than the Street is appreciating; 4) a turnaround will take longer than expected or is not possible; and 5) the debtholders have an advantaged position in the capital structure, and as such the equity holders are at their mercy, especially in a bankruptcy situation. We believe investors would consider this as a sign that the next several years may not represent a major turnaround for the company.

    Shares of Valeant have dropped 11% to$10.76 at 3:12 p.m.

  • [By Peter Graham]

    Controversialmid capspecialty pharmastockValeant Pharmaceuticals International (NYSE: VRX) reportedQ1 2017 earnings before the market opened this morning with shares soaring in premarket trading. Valeant Pharmaceuticalshad beenwidelycriticized for pioneering the highly lucrative business model of acquiring pharmaceutical companies or their drugs, incorporating these drugs intoits sales and supply chain and thenjacking up the prices of these medications to levels contemporaneous with similar pharmaceutical products. In February 2016,the Companydisclosed that it was under investigation by the SEC and by the U.S. Attorney’s Offices for the Southern District of New York and then came under further criticism from politicians.

  • [By Ben Levisohn]

    Deutsche Bank’sGregg Gilbert andGreg Fraser cut their price target on Valeant Pharmaceuticals International (VRX) to $24 from $29, but say they “like the set-up for the stock in the short-term.” They explain why:

Top 10 Heal Care Stocks To Invest In Right Now

&l;p&g;Don&a;rsquo;t let anybody fool you; retirement investing today is like rocket science. The days of picking your favorite company to invest in are long gone. In this market, success comes by optimizing your portfolio, so you receive all that you are entitled to and get the very best returns, along with managing risk, so you don&a;rsquo;t lose more than what is necessary when, not if, the market corrects or crashes again.

&l;img class=&q;wp-image-46 size-large&q; src=&q;http://blogs-images.forbes.com/impactpartners/files/2018/02/GettyImages-626673360-1200×800.jpg?width=960&q; alt=&q;&q; data-height=&q;800&q; data-width=&q;1200&q;&g; Don&a;rsquo;t let anybody fool you; retirement investing today is like rocket science.

The closer to retirement you get, the more important this is.

There are three legs of the investment retirement stool that are essential to achieving financial success:

&l;strong&g;1. Do the planning&l;/strong&g;. This is the part that nobody wants to do because it&a;rsquo;s the hardest and least fun. However, before you can even approach the investing game, you must first tell your money what to do. Otherwise, it will do the wrong thing or nothing at all.

Top 10 Heal Care Stocks To Invest In Right Now: FMC Corporation(FMC)

Advisors’ Opinion:

  • [By ]

    FMC Corp (FMC) : “I like the way it’s bottoming and I think this level is good.”

    Pennsylvania Real Estate Investment (PEI) : “I think this REIT is cheap and they can pay that dividend, so you can own it.”

  • [By ]

    In the Lightning Round, Cramer was bullish on FMC Corp (FMC) , Pennsylvania Real Estate Investment Trust  (PEI) , Cisco Systems (CSCO) , HP (HPQ) , BB&T Bank (BBT) and HCA Holdings (HCA) .

  • [By Ben Levisohn]

    We also want to reiterate our bullish view on the agricultural commodities and the ag-related stocks (e.g., CF Industries Holdings (CF), Mosaic (MOS), Potash Corp. of Saskatchewan (POT), FMC (FMC), AGCO, Deere). Following sharp multi-year declines, trends continue to improve.

  • [By WWW.THESTREET.COM]

    With an improving global economy, now is a great time to be a chemical company, Cramer told viewers, as he reiterated his favorites: Albemarle (ALB) and FMC Technology  (FMC) .

  • [By Beth McKenna]

    Most investors interested in gaining exposure to the lithium space should stick with investing in one or more of the large players listed on a major U.S. stock exchange:Albemarle Corporation(NYSE:ALB), FMC Corp. (NYSE:FMC), andSociedad Quimica y Minera de Chile(NYSE:SQM), or SQM. Smaller players are speculative to varying degrees, and most are unprofitable.

Top 10 Heal Care Stocks To Invest In Right Now: (CVKEY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    For example, Evergrande Life – a unit of property developer China Evergrande Group (OTC:EGRNF) – saw its premiums increase more than 40-fold in 2016. It used the proceeds to accumulate a significant stake in rival developer China Vanke (OTC:CVKEY) last year.

  • [By SEEKINGALPHA.COM]

    Another illustration of the excellent project structuring skills that First Sponsor’s management possesses relates to the divestment of a 70% interest in its property development project in China, the Star of East River project in Dongguan to Chinese property developer China Vanke (OTC:CVKEY) in FY2016. It recorded a disposal gain of S$97.3 million in 4QFY2016 and recouped its capital investment in its entirety with a surplus cash return of approximately S$23.2 million. More importantly, First Sponsor still retains exposure to the Star of East River project with a 30% interest while having a brand-name listed property developer like China Vanke leading the project.

  • [By SEEKINGALPHA.COM]

    On December 14, 4-Traders reported “BYD signed a strategic partnership agreement” with China Vanke (OTC:CVKEY), China’s largest property developer. The partnership will integrate Vanke’s property development and BYD’s cloud rail, providing a solution for urban development. BYD is also partnering (with 42 others) in a 5G joint innovation center with China Mobile (NYSE:CHL).

Top 10 Heal Care Stocks To Invest In Right Now: International Business Machines Corporation(IBM)

Advisors’ Opinion:

  • [By Paul Ausick]

    International Business Machines Corp. (NYSE: IBM) traded up 1.97% at $170.10. The stock’s 52-week range is $116.90 to $170.62, a new 52-week high posted today. Volume was nearly 3 times the daily average of around 3.5 million shares. The company had no specific news.

  • [By ]

    Here’s everything you must know before Wednesday’s opening bell:

    IBM (IBM) said revenue for the three months ended in March rose 5% to just more than  $19 billion. A preliminary examination of the blown jet engine of a Southwest Airlines (LUV) reportedly showed evidence of ‘metal fatigue.’  CSX (CSX) reported a top-and bottom-line beat for the first quarter, driven by lower costs and restructuring expenses. The IRS is giving taxpayers an extra day to file due to major outages on its website yesterday. U.S. stock futures pointed modestly higher on a strong beginning to corporate earnings season. 

    Subscribe to our Youtube Channel for extended interviews, Cramer Replays, feature content, and more!

  • [By ]

    In Pirates of Silicon Valley, an old made-for-TV movie about the PC industry’s early days, the Bill Gates character quips (in reference to IBM’s (IBM) willingness to let Microsoft (MSFT)  supply the OS for its PCs) that success is a menace, since it fools smart people into thinking that they can’t lose. Bezos’s remarks, as well as those made at times by other Amazon execs, suggest Amazon puts a lot of effort into making sure the company doesn’t lose its edge on account of its success.

  • [By Money Morning Staff Reports]

    “[RadioShack management] led the company from one declining business to another – International Business Machines (NYSE: IBM), PC-compatible Tandy Computers, and ‘The Repair Shop’ at RadioShack – and from one declining brand to another (e.g., Realistic, Optimus, Presidian, and Accurian),” Forbes stated.

Top 10 Heal Care Stocks To Invest In Right Now: Zion Oil & Gas Inc(ZN)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, energy shares fell by 0.76 percent. Meanwhile, top losers in the sector included Whiting Petroleum Corp (NYSE: WLL), down 6 percent, and Zion Oil & Gas, Inc. (NASDAQ: ZN) down 7 percent.

  • [By Lisa Levin]

    Shares of Zion Oil & Gas, Inc. (NASDAQ: ZN) got a boost, shooting up 20 percent to $5.07.

    Spark Energy Inc (NASDAQ: SPKE) shares were also up, gaining 12 percent to $19.40. Guggenheim upgraded Spark Energy from Neutral to Buy.

  • [By Lisa Levin]

    Shares of Zion Oil & Gas, Inc. (NASDAQ: ZN) got a boost, shooting up 47 percent to $6.21.

    Spark Energy Inc (NASDAQ: SPKE) shares were also up, gaining 10 percent to $19.10. Guggenheim upgraded Spark Energy from Neutral to Buy.

Top 10 Heal Care Stocks To Invest In Right Now: Arrow Electronics, Inc.(ARW)

Advisors’ Opinion:

  • [By Brian Mathews]

    Arrow Electronics Inc. (NYSE: ARW) is one of the world’s largest distributors of electric components and computer products. During 2015, ARW struggled primarily due to unfavorable currency fluctuations. However, the company has been seasonal toward the end of the year, especially in Europe, and is expected to carry that positive momentum into the New Year. Arrow has packaged its core products and value-added services into a comprehensive solution that lowers the cost base over a product’s lifetime, yet adds higher client engagement. With a diversified product line and successful current strategy, Arrow is well positioned to grow to a target price of $65.

Top 10 Heal Care Stocks To Invest In Right Now: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By Virendra Singh Chauhan]

    Nvidia corporation stock shook off the bad performance from the last week, with a nearly 3% gain in the first trading session of this week. If you are wondering whether or not NVIDIA stock has turned the corner, a recent tweet from NVIDIA bear Andrew Left offers some answers. In late December, Citron’s Andrew Left issued a bearish NVDA call, calling a $90 bottom on the stock. Well, the famed short seller of Valeant (NYSE:VRX) fame, recently disclosed that he had covered its short position on NVIDIA. Given that Citron had originally called for a $90 price target, it appears likely that Citron thinks NVDA stock has bottomed out $10 above its original target.

  • [By Paul Ausick]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped about 5.8% Monday, to post a new 52-week low of $12.30 after closing at $13.06 on Friday. The stock’s 52-week high is $70.43. Volume was about 50% above daily average of around 16.2 million shares. The company paid down about $1.1 billion in secured term loans and now seeks to refinance and amend its existing credit agreement, borrow more money under the agreement, and issue new secured debt.

  • [By Paul Ausick]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped about 0.1% Thursday to post a new 52-week low of $9.49 after closing Wednesday at $9.50. The stock’s 52-week high is $38.50. Volume of about 15 million shares was about 25% below the daily average of around 19 million. The company had no specific news.

Top 10 Heal Care Stocks To Invest In Right Now: BioPharmX Corporation(BPMX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of BioPharmX Corp (NYSE: BPMX) were down 31 percent to $1.02 after the company announced the pricing of 3.6 million share common stock.

    Puma Biotechnology Inc (NYSE: PBYI) was down, falling around 22 percent to $27.53 after the company issued an update to the timeline for the filing of a new drug application. Puma Biotechnology will submit the NDA for neratinib in mid-2016. According to a press release, the decision was based on the company’s recent meetings with the U.S. Food and Drug Administration.

Top 10 Heal Care Stocks To Invest In Right Now: BioScrip, Inc.(BIOS)

Advisors’ Opinion:

  • [By Chris Lange]

    On Tuesday, BioScrip Inc. (NASDAQ: BIOS) reported third-quarter financial results before the markets opened. The company said that it had a net loss of $0.09 per share and $224.5 million in revenues. The consensus estimates from Thomson Reuters had called for a net loss of $0.05 per share and revenues of $223.26 million. The same period of last year reportedly EPS of had $0.04 and $247.22 million in revenues.

  • [By Chris Lange]

    BioScrip, Inc. (NASDAQ: BIOS) saw its shares make a solid gain on Tuesday after another analyst issued a positive rating on the stock. Lake Street Capital initiated its coverage with a Buy rating and a $4.50 price target. This is implying an upside of over 300% from the previous closing price of $1.04.

  • [By Money Morning News Team]

    BioScrip Inc.(Nasdaq: BIOS) provides at-home medical care and services across the United States.

    BIOS’s central profit opportunity is in the rapid growth of the pharmaceutical industry. The pharmaceutical market is currently worth $12 billion and is expected to grow at an annual rate of five to seven percent.

Top 10 Heal Care Stocks To Invest In Right Now: MiMedx Group, Inc(MDXG)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap regenerative biomaterial product and bioimplant stock MiMedx Group Inc (NASDAQ: MDXG) is thethirteenth most shorted stock on theNASDAQ with short interest of 40.54% according to Highshortinterest.com. MiMedx Group isa leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing proprietary PURION庐 Process among other processes, to produce safe and effective allografts.MiMedx Group is the leading supplier of placental tissue, having supplied over 1,000,000 allografts to date for application in the Wound Care, Burn, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare.

  • [By Paul Ausick]

    MiMedx Group Inc. (NASDAQ: MDXG) dropped nearly 23% Monday to post a new 52-week low of $6.05. Shares closed at $7.83 on Friday and the stock’s 52-week high is $18.25. Volume was over 22 million, about 10 times the daily average. The company postponed is quarterly report last week in order to conduct an accounting review and Bloomberg reported today that a U.S. Justice Department investigation is underway.

  • [By ]

    Some stocks are just too hard to take a position in, Cramer told viewers, as he dove into the stock of MiMedx (MDXG) , a small-cap biopharma that converts donated placental tissue into skin grafts that help in the recovery for a host of ailments.

Top 10 Heal Care Stocks To Invest In Right Now: Popeyes Louisiana Kitchen, Inc.(PLKI)

Advisors’ Opinion:

  • [By Daniel Miller]

    While chicken and burgers might not sound like a match made in heaven for dinner, it could be tasty for investors inRestaurant Brands International (NYSE:QSR). The parent company of Burger King agreed to purchase Popeyes Louisiana Kitchen Inc. (NASDAQ:PLKI).

  • [By Ashley Moore]

    Popeyes Louisiana Kitchen Inc. (Nasdaq: PLKI) stock is up 19% today (Tuesday) after Burger King’s parent company, Restaurant Brands International Inc. (NYSE: QSR), announced it will buy the fast-food chicken company.

  • [By Monica Gerson]

    Popeyes Louisiana Kitchen Inc (NASDAQ: PLKI) is estimated to post its quarterly earnings at $0.64 per share on revenue of $85.31 million.

    SpartanNash Co (NASDAQ: SPTN) is expected to post its quarterly earnings at $0.49 per share on revenue of $2.28 billion.

Top 5 Canadian Stocks To Buy Right Now

New Gold (NYSEMKT:NGD) is a mid-tier gold producer, poised to become one of the gold majors. The Canadian company operates four gold mines located in safe jurisdictions (Canada, USA, Australia, Mexico) and it develops two new major gold mines. The Rainy River mine is under construction and it should be completed in summer of 2017. The Blackwater mine is in the permitting process, with the start of construction expected in 2018. Thanks to Rainy River and Blackwater, New Gold is in a unique position. It is going to grow its production rapidly, while maintaining a low level of political risks, as both Rainy River and Blackwater are located in Canada.

Top 5 Canadian Stocks To Buy Right Now: Talisman Energy Inc.(TLM)

Advisors’ Opinion:

  • [By Jayson Derrick]

    On the other hand, the analysts are Underweight on Eni SpA (ADR) (NYSE: E), Repsol Oil & Gas Canada Inc (USA) (NYSE: TLM) and OMV AG given their asset bases, which offer an inferior risk to reward profile and limited differentiation in cost reductions.

Top 5 Canadian Stocks To Buy Right Now: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By Ashley Moore]

    This next company to short continues to make headlines for its purportedly illegal business practices…

    Stocks to Short No. 2: Valeant Pharmaceuticals International Inc. (NYSE: VRX)

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) is known for its questionable business practices. The company is notorious for buying smaller pharmaceutical companies (financed with debt), firing the staff of the newly acquired company, and dramatically raising prices of the new drugs at its disposal.

  • [By Lisa Levin]

    Healthcare shares rose by 1.68 percent in the US market on Thursday. Top gainers in the sector included Sangamo Therapeutics Inc (NASDAQ: SGMO), Valeant Pharmaceuticals Intl Inc (NYSE: VRX), and Tenet Healthcare Corp (NYSE: THC).

  • [By Ben Levisohn]

    If it feels like it’s been all Valeant Pharmaceuticals International (VRX) today, I get it, and I promise this will be my last post on the company today. But really, how often do we get to see a fund manager acknowledge a spectacular mistake in such publicfashion?

    Photo: Andrew Harrer/Bloomberg

    As if it weren’t obvious yet, Ackman’s exit is bad news for the stock.Yes, some analysts have tried to focus on other issues that could be positive, but, really, as long as Ackman was around, you knew someone big had Valeant’s back. And now he’s gone. We at Barron’s were never too enthusiastic about Valeant–Vito Racanelliwrote bearishly on the company 2014–or Ackman’s involvement. But it he was your reason to be in Valeant, well consider what Wells Fargo analyst David Maris has to say:

    …we believe investors will take Pershing Squares exit as a reflection that 1) the outlook is negative; 2) the potential for meaningful near-term asset sales is unlikely; 3) the legal proceedings/investigations may have greater risk than the Street is appreciating; 4) a turnaround will take longer than expected or is not possible; and 5) the debtholders have an advantaged position in the capital structure, and as such the equity holders are at their mercy, especially in a bankruptcy situation. We believe investors would consider this as a sign that the next several years may not represent a major turnaround for the company.

    Shares of Valeant have dropped 11% to$10.76 at 3:12 p.m.

Top 5 Canadian Stocks To Buy Right Now: Plains All American Pipeline L.P.(PAA)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    One of the largest projects is the Saddlehorn Pipeline, which Magellan is building with Plains All American Pipeline (NYSE:PAA) and Anadarko Petroleum (NYSE:APC). Both Plains All American Pipeline and Magellan own 40% of the project, which puts their total investment at $230 million apiece. They expect the project to be fully operational early next year, which is noteworthy given its robust first-year economics. Magellan estimates that it will earn eight times EBITDA on the capital deployed, or roughly $28.8 million in annual EBITDA apiece for Magellan and Plains All American Pipeline on their investment.

  • [By Dustin Parrett]

    We think Plains All American Pipeline L.P. (NYSE: PAA) is one of the best oil stocks to buy this year. In fact, we see a scenario where PAA stock could jump 20% in 2017.

  • [By Dustin Parrett]

    Plains All American Pipeline (NYSE: PAA) controls 4 million barrels of crude oil and natural gas a day.

    And with higher oil prices and fewer restrictions leading to more drilling, PAA’s pipelines will be in demand in 2017.

Top 5 Canadian Stocks To Buy Right Now: Credit Suisse Group(CS)

Advisors’ Opinion:

  • [By David Zeiler]

    The federal government’s largesse isn’t restricted to U.S.-based companies, either. Foreign companies, including foreign banks, are also welcome. Credit Suisse Group AG (NYSE ADR: CS) got $225.1 billion, and UBS Group AG (NYSE: UBS) got $249.1 billion.

  • [By Money Morning News Team]

    That’s why Krauth predicts the price of gold will hit $1,400 by the end of the year. Many analysts from banks likeCredit SuisseGroup AG (NYSE ADR: CS) even see gold going as high as $1,500.

  • [By Wayne Duggan] Related DB Deutsche Bank In The Tank Mike Khouw Sees Unusual Options Activity In Deutsche Bank 33 Large Banks On The Federal Reserve's Radar In 2016 (Seeking Alpha)
    Related CS Earnings Scheduled For February 4, 2016 Blockchain Moves Forward In The Financial Industry Credit Suisse Group AG (CS) Tidjane Thiam on Q4 2015 Results – Earnings Call Transcript (Seeking Alpha)

    The latest credit default swap (CDS) data from BMO Capital Markets indicate a number of investors are growing increasingly concerned about the one-year outlook for capital markets. In a new report, analyst Mark Steele discussed the recent surge in one-year CDS activity, and what it means for the market.

Top 5 Canadian Stocks To Buy Right Now: Patni Computer Systems Limited(PTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Proteostasis Therapeutics Inc (NASDAQ: PTI) shares shot up 162 percent to $6.16 after the company disclosed 'positive' PTI-428 data with statistical significance.

  • [By William Romov]

    Before we show you our pick, here are the top 10 penny stocks to watch this week

    Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
    Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
    Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
    Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
    UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
    WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
    PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
    EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
    Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free

Top 10 Stocks To Watch For 2018

Your Pizza Hut delivery could one day arrive via a self-driving Toyota van.

Toyota unveiled a concept vehicle called e-Palette, which could host a mobile store, act as a ride-sharing service or deliver packages. The announcement was unveiled at International CES in Las Vegas on Monday.

The automaker said it is teaming up with a handful of partners, including Pizza Hut, Amazon, Chinese ridesharing giant Didi and Uber.

“Today, you have to travel to the stores,” Toyota president Akio Toyoda said at the event. “In the future with e-Pallete, the store will come to you.”

Although e-Palette is only a concept vehicle for now, he added that the company plans to pilot the technology at the 2020 Olympic Games in Tokyo. Tests in the U.S. and other areas are envisioned for the early 2020s.

Introducing the first Pizza Hut fully autonomous delivery concept vehicle. Excited for our future with @Toyota #CES2018 pic.twitter.com/YGNQUgijha

Top 10 Stocks To Watch For 2018: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) sawits shares hit a multiyear low this past week. There was hope for a turnaround when Joe Papa took over as chief executive officer,but it seems that littlehas gone his way, especially after the company reported earnings early this week. Some analysts took this opportunity to reevaluate their stance on the stock. Although this might be a buy for some, the returns look to be getting smaller.

  • [By Paul Ausick]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped about 6.2% Friday, to post a new 52-week low of $12.90 after closing at $13.75 on Thursday. The stock’s 52-week high is $70.43. Volume was about double the daily average of around 15.9 million shares. The company completed the sale of some skincare brands to L’Or茅al.

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) made waves early on Tuesday after the company offered a plethora of announcements. First the company gave an update on its late-stage psoriasis trial. Along with this success, Valeant reported the sale of a couple of its business segments, bringing in a sizable amount of cash.

  • [By Kumar Abhishek] Valeant Pharmaceuticals(NYSE:VRX) stock jumps after the company sold Dendreon for hefty gains.
    Flickr

    Shares of Valeant (NYSE:VRX) jumped more than 14% in pre-market trading yesterday, after the Canadian drug maker announced its long-awaited asset sale plans. The stock later gave away some of its gains after Moody’s released a report stating that the asset sales will not impact its credit rating or outlook, though Valeant’s bond prices jumped by 4.5%. Valeant is a classic example of a shareholder value destroyer. Once the darling of Wall Street, the stock has lost more than 90% of its value since its peak in 2014 and is down by more 80% in the last one year. The stock has dragged portfolios of the likes of Bill Ackman and Prof. Aswath Damodaran. However, the asset saleprovides a ray of hope for Valeant’s shareholders.

  • [By WWW.THESTREET.COM]

    Bond prices were much lower early in the day, with yields up by nearly 10 basis points. But fixed income has rallied back (reducing the drop by half on the day). Valeant Pharmaceuticals (VRX) , more weakness. Large pharma lower, led by Eli Lilly (LLY) . Old tech lags, with International Business Machines (IBM) , Intel (INTC) , Cisco Systems (CSCO) and Microsoft (MSFT) all lower. Media roughed up a bit (CBS (CBS) and Comcast (CMCSA) ). The Ugly
    Gold down another $23 to $1,188 (SPDR Gold Trust ETF (GLD) down $2.25). Urban Outfitters (URBN) down $5. NOTE: There will be no “Takeaways” today!   Happy Thanksgiving. Position: Long GLD small, SDS large, JCP large; short SPY, CSCO, CAT small, IWM, TLT small.

  • [By Wayne Duggan]

    Market laggards that could come under additional window dressing selling pressure include Valeant Pharmaceuticals Intl Inc (NYSE: VRX), Endo International plc – Ordinary Shares (NASDAQ: ENDP) and NewLink Genetics Corp (NASDAQ: NLNK).

Top 10 Stocks To Watch For 2018: CVR Refining, LP(CVRR)

Advisors’ Opinion:

  • [By Tyler Crowe]

    For refiners, though, that spread in price led to very lucrative refining margins. As that spread has narrowed, so too has margins for refiners.

    Refining Margins Q4 2012 Q2 2013
    Valero (NYSE: VLO  ) $12.27 $9.26
    Phillips 66 (NYSE: PSX  ) $13.67 $9.88
    HollyFrontier (NYSE: HFC  ) $24.00 $20.28
    CVR Refining (NYSE: CVRR  ) $28.08 $20.30

    Source: Company Earnings releases

  • [By Robert Rapier]

    CVR Partners’ fertilizer plant is located in Coffeyville, Kansas, adjacent to the refinery owned by CVR Refining (NYSE: CVRR). CVR Energy (NYSE: CVI), majority-owned by Carl Icahn via Icahn Enterprises (NYSE: IEP), is the general partner and owns most of the units for both CVR Partners and CVR Refining.

  • [By Lisa Levin]

    Shares of CVR Refining LP (NYSE: CVRR) were down 11 percent to $10.00. Velocity Midstream Partners and CVR Refining disclosed the execution of agreements related to the construction of a crude oil pipeline from the SCOOP play in Central Oklahoma to CVR's Wynnewood refinery.

Top 10 Stocks To Watch For 2018: Euro/Yen(EJ)

Advisors’ Opinion:

  • [By Belinda Cao]

    E-House China Holdings Ltd. (EJ), a real estate brokerage, gained 9.2 percent to $9.70, extending it advance to a third week. Its American depositary receipts retreated 3.1 percent Sept. 20 from the highest level since May 2011.

Top 10 Stocks To Watch For 2018: Brink's Company (The)(BCO)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    World Wrestling Entertainment (NYSE: WW) received a pair of downgrades after its earnings report came in below estimates.

    Sell-Side's Most Noteworthy Calls
    Baird downgraded Cardinal Health (NYSE: CAH) to Neutral.
    Imperial downgraded Brinks (NYSE: BCO) to In-Line.
    Jefferies upgraded AK Steel (NYSE: AKS) to Buy.
    Craig-Hallum upgraded LendingClub (NYSE: LC) to Buy.
    Deal Talk

    General Electric (NYSE: GE) was said to be in talks to acquire Baker Hughes (NYSE: BHI), according to sources as reported by Dow Jones. A deal could be valued at as much as $30 billion. However, Bloomberg later reported that a GE spokesperson said they're in talks with Baker Hughes regarding possible partnerships, but not an acquisition. Halliburton (NYSE: HAL) had attempted to acquire Baker Hughes in 2014, but the DoJ sued to block the deal valued at $35 billion.

  • [By Lee Jackson]

    Another hedge fund that is also a director at Brink’s Co. (NYSE: BCO) was busy selling stock this past week. Starboard parted with a total of 650,000 shares of the security and protection company at prices that fell between $51.47 and $52.05. The total for the sale was set at $34 million. Shares closed on Friday at $52.00. The consensus price target is $56, and the52-week range is $26.86 to $53.90.

Top 10 Stocks To Watch For 2018: Axsome Therapeutics, Inc.(AXSM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Axsome Therapeutics Inc (NASDAQ: AXSM) shares dropped 18 percent to $3.62. Axsome Therapeutics priced 3.74 million shares at $3.74 per share.

    Shares of Canadian Solar Inc. (NASDAQ: CSIQ) were down around 11 percent to $12.10 after the company posted downbeat quarterly earnings and issued a weak forecast.

  • [By William Romov]

    Currently trading at $4.85, Manhattan-based Axsome Therapeutics Inc. (Nasdaq: AXSM) makes drugs to treat depression, Alzheimer’s disease, and chronic pain.

  • [By Jim Robertson]

    On Tuesday, ourUnder the Radar Moversnewsletter suggested shorting small cap clinical-stage biopharmaceutical stock Axsome Therapeutics (NASDAQ: AXSM):

  • [By Paul Ausick]

    Axsome Therapeutics Inc. (NASDAQ: AXSM) traded down about 43% Tuesday and posted a new 52-week low of $3.20 after closing Monday at $5.55. The 52-week high is $6.45. Volume was about 3.8 million, about 19 times the daily average of around 220,000 shares. The company will stop a “futile” portion of a trial of its treatment for knee osteoarthritis.

Top 10 Stocks To Watch For 2018: Luby's, Inc.(LUB)

Advisors’ Opinion:

  • [By Monica Gerson]

    Luby’s, Inc. (NYSE: LUB) is expected to post earnings for the latest quarter.

    Simulations Plus, Inc. (NASDAQ: SLP) is estimated to post its quarterly earnings at $0.07 per share on revenue of $5.00 million.

Top 10 Stocks To Watch For 2018: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

Top 10 Stocks To Watch For 2018: Oak Valley Bancorp (CA)(OVLY)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, financial shares fell 0.32 percent. Meanwhile, top losers in the sector included Oak Valley Bancorp (NASDAQ: OVLY), down 7 percent, and AmTrust Financial Services Inc (NASDAQ: AFSI) down 5 percent.

Top 10 Stocks To Watch For 2018: Corbus Pharmaceuticals Holdings, Inc.(CRBP)

Advisors’ Opinion:

  • [By Sean Williams]

    This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.

    GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%

    As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!

  • [By Keith Speights]

    Corbus Pharmaceuticals (NASDAQ:CRBP) managed to become one of the top-performing biotech stocks on the market in 2016. Over the last 12 months, Corbus’ share price has soared 550%.

Top 10 Stocks To Watch For 2018: Texas Roadhouse, Inc.(TXRH)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Texas Roadhouse Inc. (NASDAQ: TXRH) was raised to Buy from Neutral at BTIG Research.

    USG Corp. (NYSE: USG) was reiterated as Hold but the price target was raised to $35 from $29 (versus a $34.23 close) at Jefferies.

  • [By Joe Tenebruso]

    Fortunately, well-chosen dividend-growth stocks can help you accomplish both of these goals. And with its powerful wealth-building combination of increasing dividend payouts and share-price appreciation, Texas Roadhouse (NASDAQ:TXRH)is one of the best available in the market today.

  • [By Teresa Rivas]

    Texas Roadhouse(TXRH) tumbled more than 12% on Wednesday as itsfourth-quarter earningsand revenue fell short of expectations.

    Pixabay

    The restaurant chain said it earned 29 cents a share on revenue of $484.7 million. Analysts were expecting earnings per share of 38 cents on revenue of $497.3 million.

    Same-restaurant sales grew 1.2% at company restaurants and 2% at domestic franchises. For the first 55 days of the first quarter, Texas Roadhouse said that same-store sales rose 1.5%.

    The company also raised its dividend 10.5% to 21 cents a share.

    Some analysts urged investors to keep the faith in the stock.Barclay’s JeffreyBernsteinreiterated an Overweight rating and $47 price target on thestock:

    We believe TXRH fundamentals remain best-in-class. That said, the near-term focus remains on directional comps. And not unlike the broader industry, TXRH comps eased significantly to close 2016. Such led to disappointing 4Q16 results from top to bottom. Importantly, while the brand ‘is not immune’ to industry comp headwinds, the relative outperformance to the category was maintained. Looking to 2017, key guidance metrics were reiterated. While questions remain on whether the recent easing of industry comps will persist, we remain comforted by TXRH’s relative outperformance and easing comps as we move through 2017.

    Maxim’s Stephen Andersonreiterated a Buy rating, although he took his price target down $4, to $52:

    In our view, TXRH is not immune to the broader slowdown in Casual Dining, but we believe the company will emerge stronger than peers in the next few quarters.TXRHs disappointing 4Q16 comp of +1.3% (blended) was pulled down by a rare negative comp month in December (-2.1%), marking the first time this occurred in almost four years. Comps were +3% or better in both October and November, and comps so far in 1Q17 are positive despite a stormy start to the quarter in

  • [By Dan Caplinger]

    Steakhouse chain Texas Roadhouse (NASDAQ:TXRH) has had to deal with an extremely difficult business environment for restaurant companies, and investors know all too well how tough times can hurt major players in the industry. Last quarter, Texas Roadhouse disappointed investors with sluggish results, and the company wanted to start 2017 on a better footing.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, Texas Roadhouse (NASDAQ:TXRH) and Garmin (NASDAQ:GRMN)made large moves following their quarterly earnings announcements.